Heligenics
@heligenics.com
Heligenics believes that people can live healthier lives. We rdevelop advanced diagnostics and better Biologic drugs by analysis of the function of genetic variation. We are the first biotechnology company to analyze all mutations in a gene at once. Heligenics is modernizing drug discovery by taking High Content Screening developed for small molecule drugs and applying it to the new class of Biologic drugs like Insulin, GLP1, and antibody therapies.
Heligenics's Company Logos
Heligenics's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#3899EC
Picton Blue
56, 153, 236
208, 83, 57
76, 35, 0, 7
#91F8E5
Aquamarine
145, 248, 229
169, 88, 77
42, 0, 8, 3
#036894
Bahama Blue
3, 104, 148
198, 96, 30
98, 30, 0, 42
About Heligenics
Heligenics is a pioneering biotechnology company specializing in functional genomics research and services. Established in 2017 by Dr. Martin Schiller, a prominent figure at the University of Nevada, our mission is to leverage the power of genomics to advance precision medicine and bring about healing.
With a name derived from the Old English word hǣlan, meaning to heal, and genics, representing genomics, our brand encapsulates our commitment to revolutionizing healthcare. At Heligenics, we offer comprehensive genomic solutions to pharmaceutical and biotechnology companies, as well as healthcare providers, to drive personalized medicine and precision therapeutics forward. Our expertise lies in understanding the impact of genetic variations on gene function, disease development, and drug response.
Our services range from constructing large variant libraries and conducting cell-based GigaAssays for functional consequence analysis to developing MEGA-Maps for resolving variant-detection challenges in diagnostics. What sets Heligenics apart is our innovative approaches and proprietary technologies. As the first company to enable high-content screening for biologics in the pharmaceutical space, we empower our clients to delve deeper into the functional consequences of genetic variations and design more effective, individualized treatments.
This has cemented our position as a leader in the field of functional genomics. Our groundbreaking GigaAssay technology, developed at the University of Nevada Las Vegas in the Schiller Laboratory of Applied Bioinformatics, serves as the cornerstone of our approach. This massively parallel biological platform allows for the simultaneous measurement of tens of thousands of genetic variants or other sequence variables, enabling unprecedented insights into molecular function and cellular processes.
The resulting functional genomics data can be licensed for various applications, including prevention-based approaches, diagnostics, drug selection, and the discovery of new biologic drugs. Driven by our commitment to progress, Heligenics is transforming the medical industry. With an A+ rating from the Better Business Bureau and two successful funding rounds, we are dedicated to advancing precision medicine and ultimately preventing disease and healing patients through the power of genomics.
Contact us today to explore how our pioneering solutions can revolutionize your approach to healthcare
Company type
Privately Held
Year founded
2017
Company size
2-10 employees
